000 | 00898 a2200241 4500 | ||
---|---|---|---|
005 | 20250515223240.0 | ||
264 | 0 | _c20110617 | |
008 | 201106s 0 0 eng d | ||
022 | _a1177-5483 | ||
024 | 7 |
_a10.2147/opth.s8598 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGhazi, Nicola G | |
245 | 0 | 0 |
_aIs monthly retreatment with intravitreal bevacizumab (Avastin) necessary in neovascular age-related macular degeneration? _h[electronic resource] |
260 |
_bClinical ophthalmology (Auckland, N.Z.) _cApr 2010 |
||
300 |
_a307-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aKirk, Tyler Q | |
700 | 1 | _aKnape, Robert M | |
700 | 1 | _aTiedeman, James S | |
700 | 1 | _aConway, Brian P | |
773 | 0 |
_tClinical ophthalmology (Auckland, N.Z.) _gvol. 4 _gp. 307-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2147/opth.s8598 _zAvailable from publisher's website |
999 |
_c19818472 _d19818472 |